Stop poorly made generic drugs from India and Isreal Now!

This affects everyone including everyone you know your family friends, neighbors and you. Sadly, the FDA rarely makes any generic drug data available. This lack of transparency drives us crazy. Physicians, pharmacists, patients and insurance companies should all have ready access to the bioequivalence curves the FDA uses to determine if a generic drug is indeed equal to its brand name counterpart. We learned with the antidepressant bupropion that the FDA messed up badly when it approved generic Budeprion XL 300 for the brand Wellbutrin XL 300.